Browsing Category
Pharma Industry News
4765 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
American Regent’s HEART-FID trial for INJECTAFER fails to meet primary endpoint
American Regent, Inc., a subsidiary of Daiichi Sankyo Group, has announced disappointing results from its phase 3 HEART-FID…
Botanical Solution Inc. raises additional $7m in Series A funding round
Delaware-based Botanical Solution Inc. (BSI) has announced a new influx of $7 million in investment, bringing the total…
Merck launches Phase 3 CORALreef program for PCSK9 inhibitor MK-0616
Pharmaceutical giant Merck has announced the initiation of its groundbreaking Phase 3 clinical program, CORALreef, focusing on MK-0616—a…
Nura Bio kicks off Phase 1 clinical trials for SARM1 inhibitor NB-4746
Nura Bio, a leading biopharmaceutical company specializing in neuroprotective, small molecule therapies, announced today the initiation of Phase…
Lupin Limited gains FDA approval for generic equivalent of Esbriet Tablets
Lupin Limited announced today that it has secured approval from the United States Food and Drug Administration (US…
Zydus Lifesciences gets FDA nod for Zinc Sulfate Injection
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for its…
Immunomic Therapeutics begins ITI-1001 Phase 1 trial in glioblastoma
Immunomic Therapeutics, Inc., a clinical-stage biotech company specializing in nucleic acid immunotherapy platforms, has dosed the first patient…
FDA greenlights Pfizer’s ABRYSVO vaccine for shielding infants from RSV
The US Food and Drug Administration (FDA) has granted approval to Pfizer Inc.’s ABRYSVO, a bivalent Respiratory Syncytial…
China’s NMPA expands AstraZeneca’s Forxiga use as heart failure treatment
China’s National Medical Products Administration (NMPA) has approved AstraZeneca’s Forxiga (dapagliflozin) for diminishing the risk of cardiovascular fatalities…
EMA validates LEO Pharma’s application for delgocitinib cream in chronic hand eczema
LEO Pharma A/S said that the European Medicines Agency (EMA) has validated its marketing authorization application (MAA) for…